Scott M. Rocklage, Director at Aprea Therapeutics, Inc. (APRE), sold 255,000 shares at $35.15 ($9.0M) on 2020-05-19, disclosed to the SEC on 2020-05-21.
Open-market sale of $9.0M APRE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.15 | 10,200 | $359K | 4.0% |
| 2 | $35.15 | 244,800 | $8.6M | 96.0% |
| Total | $35.15 avg | 255,000 | $9.0M | 100% |
| Filing → |
| APRE | SELL | 2020-06-18 | $8.0M | — | Filing → |
| APRE | SELL | 2020-06-15 | $7.0M | — | Filing → |
| CRNX | SELL | 2019-06-25 | $5.5M | — | Filing → |